Ubrigene is a China-based CDMO that develops and commercializes cell and AAV-centered gene therapy technologies for the healthcare industry.
Business Model:
Revenue: $10M
Employees: 201-500
Address: 407-07, Xinnan Road
City: Beijing
State: beijing municipality
Zip: 102200
Country: CN
Ubrigene is a China-based CDMO that develops and commercializes cell and AAV-centered gene therapy technologies for the healthcare industry.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Series B | 5 | $31M |
Addor Capital Cowin Capital FOF Capital IDG Capital Ming Bioventures Addor Capital Cowin Capital FOF Capital IDG Capital Ming Bioventures |
9/2022 | Series C | - | 9/2022 | Series C | - |
CLSA Capital Partners BGI Co-win Xingtou Capital Huagai Capital FOF Capital IDG Capital CLSA Capital Partners BGI Co-win Xingtou Capital Huagai Capital FOF Capital IDG Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|